The oncology world experienced a revolution about 10 years ago as the first targeted therapies came on the scene. Researchers feverishly designed treatments that would spare healthy tissue, tackling t...
Read moreResearchers from the Spanish National Cancer Research Centre (CNIO) have “discovered one of the key genes that make up the maintenance mechanism for tissues” says Miguel Foronda, the first author ...
Read moreGkikas Magiorkinis, a clinical research fellow from the Department of Zoology at Oxford University in the United Kingdom, has traced history at a microscopic level. By combining epidemiological and mo...
Read moreJorge Barrero, adjunto a la presidencia de Asebio, advierte sobre la llegada tardía de la crisis a las 'biotec' y pide facilitar la fusión de empresas para concentrar el sector.
Read moreIt is possible that none of you heard about the Tersicoccus phoenicis. In fact, there are few who can tell that have seen it or that had it in hands. It isn’t a small mammal which lives in an isolat...
Read moreAsí lo considera un experto en geomorfología y docente de la Universidad de Washingon. Para David Montgomery, profesor de geomorfología de la Universidad de Washington y autor del libro Suciedad...
Read more'El amanecer del planeta de los simios' plantea los riesgos potenciales de los experimentos de manipulación genética con grandes primates para investigar enfermedades neurodegenerativas y nuevas ter...
Read moreMichael F Murray, director de Genómica Clínica en el Instituto de Medicina Genómica de Geisinger, Pennsylvania, EEUU, ha hablado en una entrevista publicada en Genome Medicine sobre la necesidad de...
Read moreBoehringer Ingelheim announced that for the first time the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation for a treatment in idiopathic pulmonary fibrosis (IPF), a ...
Read moreUn equipo de investigadores de la Universidad de Washington (EEUU) ha publicado en Nature que es posible encerrar el parásito del paludismo en una ‘prisión' creada por sí mismo. Cuando el par
Read moreThe Catalan Institute of Oncology (ICO) and the Bellvitge Biomedical Research Institute (IDIBELL) promote the study of certain cancers in animals. Specifically, tumors caused by infectious agents such...
Read moreResearchers at sarcomas research group at the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) have been tested in 19 patients a new therapeutic combinatio...
Read more